Walvax Biotechnology Co., Ltd. (SHE:300142)
China · Delayed Price · Currency is CNY 13.31
+0.24 (1.84%)
Sep 18, 2026, 3:04 PM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 21.29 billion as of September 18, 2026. Its market cap has increased by 7.60% in one year.
Market Cap
21.29B
Enterprise Value
21.75B
Revenue
2.10B
Ranking
n/a
PE Ratio
113.42
Stock Price
13.31
ChartMarket Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 21.29B, an increase of 56.12%. That is a compound annual growth rate of 2.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 21.29B | 22.00% |
| Dec 31, 2025 | 17.45B | -9.69% |
| Dec 31, 2024 | 19.32B | -48.62% |
| Dec 29, 2023 | 37.60B | -41.50% |
| Dec 30, 2022 | 64.27B | -28.12% |
| Dec 31, 2021 | 89.42B | 50.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hubei Jumpcan Pharmaceutical | 23.22B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.02B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.83B |
| Shanghai Haoyuan Chemexpress | 21.07B |
| Hybio Pharmaceutical | 20.76B |
| Tasly Pharmaceutical Group | 20.71B |
| Livzon Pharmaceutical Group | 20.65B |
| Jilin Aodong Pharmaceutical Group | 20.59B |